High prevalence of anemia after cardiac transplantation in children

N D Embleton1, J J O'Sullivan, J R Hamilton

  • 1Regional Cardiothoracic Centre, Freeman Hospital, Newcastle upon Tyne, England.

Transplantation
|February 12, 1998
PubMed

Insights

Anemia is common in children after heart transplants, but it

Area of Science:

  • Pediatric Cardiology
  • Transplantation Medicine
  • Hematology

Background:

  • Chronic anemia is prevalent in adult heart transplant recipients.
  • The prevalence and causes of anemia in pediatric heart transplant patients are not well-defined.
  • Iron deficiency is common in healthy children and may contribute to anemia post-transplant.

Purpose of the Study:

  • To determine the prevalence of chronic anemia in well pediatric cardiac transplant survivors.
  • To investigate the underlying causes of anemia in this population.
  • To specifically assess the role of iron deficiency in post-cardiac transplant anemia.

Main Methods:

  • Studied 20 children (7 months to 16 years) post-cardiac transplantation.
  • All participants were clinically well, 4 months to 6 years post-transplant.
  • Assessed anemia prevalence and initiated iron supplementation in anemic children.

Main Results:

  • 14 out of 20 children (70%) were anemic.
  • Low serum iron and erythropoietin levels were observed in most anemic children.
  • Only one child showed improvement with iron supplementation; hemoglobin levels remained low.

Conclusions:

  • Anemia is highly prevalent in pediatric cardiac transplant recipients.
  • Anemia is typically not caused by iron deficiency, despite low iron levels.
  • Anemia of chronic disease, potentially linked to inflammation or cyclosporine effects on erythropoietin, is likely the primary cause.
Abstract

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Blood Transfusion01:15

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...